Cargando…
Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study
BACKGROUND: Human papillomavirus (HVP)–positive oropharyngeal cancer is the most common HPV-associated cancer in the United States. The age at acquisition of oral HPV infections that cause oropharyngeal cancer (causal infections) is unknown; consequently, the benefit of vaccination of US men aged 27...
Autores principales: | Landy, Rebecca, Haber, Gregory, Graubard, Barry I, Campos, Nicole G, Sy, Stephen, Kim, Jane J, Burger, Emily A, Cheung, Li C, Katki, Hormuzd A, Gillison, Maura L, Chaturvedi, Anil K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086634/ https://www.ncbi.nlm.nih.gov/pubmed/36655795 http://dx.doi.org/10.1093/jnci/djad009 |
Ejemplares similares
-
Variation in Human Papillomavirus Vaccination Effectiveness in the US by Age at Vaccination
por: Egemen, Didem, et al.
Publicado: (2022) -
HPV16 E6 seropositivity and oropharyngeal cancer: Marker of exposure, risk, or disease?
por: Landy, Rebecca, et al.
Publicado: (2021) -
Methods for Using Race and Ethnicity in Prediction Models for Lung Cancer Screening Eligibility
por: Landy, Rebecca, et al.
Publicado: (2023) -
Incorporating medical interventions into carrier probability estimation for genetic counseling
por: Katki, Hormuzd A
Publicado: (2007) -
Diverse tumorigenic consequences of human papillomavirus integration in primary oropharyngeal cancers
por: Symer, David E., et al.
Publicado: (2022)